Skip to main content
. 2023 Feb 13;2023:1508675. doi: 10.1155/2023/1508675

Table 2.

The difference of clinical, hormonal, and metabolic characteristics between IR+/IR-groups in normal weight and obesity/overweight PCOS patents.

Variable Normal weight Obesity/overweight
IR- (n = 351) IR+ (n = 174) p IR- (n = 84) IR+ (n = 342) p
Age (y) 27.11 ± 3.26 26.74 ± 3.53 0.235 28.45 ± 4.15 27.39 ± 3.45 0.015
BMI (kg/m2) 20.63 ± 1.57 21.89 ± 1.53 0.0001 26.42 ± 2.82 28.05 ± 3.16 0.0001
WHR 0.83 ± 0.07 0.86 ± 0.07 0.0001 0.88 ± 0.10 0.93 ± 0.41 0.224
WHtR 46.45 ± 4.03 49.59 ± 4.52 0.0001 55.04 ± 4.54 58.60 ± 5.84 0.0001
E2 (pmol/l) 164.21 ± 79.14 145.94 ± 73.77 0.011 160.79 ± 80.87 148.19 ± 77.13 0.184
T (nmol/l) 1.17 ± 0.63 1.11 ± 0.53 0.294 1.13 ± 0.59 1.23 ± 0.61 0.158
LH/FSH ratio 1.74 ± 1.15 1.63 ± 0.96 0.270 1.42 ± 0.77 1.31 ± 0.70 0.213
SHBG (nmoL/l) 60.80 ± 38.18 46.94 ± 36.21 0.0001 39.91 ± 26.19 32.00 ± 29.39 0.024
FAI 2.69 ± 70 3.64 ± 3.62 0.001 3.74 ± 2.89 5.80 ± 4.41 0.0001
FGS (mmol/l) 5.24 ± 0.64 5.95 ± 0.99 0.0001 5.27 ± 0.78 6.20 ± 1.19 0.0001
F2h (mmol/l) 5.64 ± 1.17 6.68 ± 2.00 0.0001 6.50 ± 1.62 7.68 ± 2.27 0.0001
FIN (μIU/ml) 7.42 ± 2.40 16.09 ± 7.58 0.0001 8.28 ± 2.47 21.22 ± 8.14 0.0001
FI2h (μIU/ml) 56.46 ± 46.38 114.38 ± 98.81 0.0001 64.80 ± 37.11 150.68 ± 156.78 0.0001
CHO (mmol/l) 4.14 ± 0.71 4.23 ± 0.72 0.194 4.29 ± 0.79 5.64 ± 2.80 0.588
TG (mmol/l) 0.99 ± 0.53 1.56 ± 1.40 0.0001 1.40 ± 0.77 1.95 ± 1.26 0.0001
HDL-C (mmol/l) 1.39 ± 0.28 1.29 ± 0.32 0.0001 1.25 ± 0.28 1.10 ± 0.21 0.0001
LDL-C (mmol/l) 2.82 ± 8.92 2.44 ± 0.66 0.582 2.59 ± 0.64 2.82 ± 2.00 0.306
LP (a) (mg/l) 143.79 ± 137.80 148.47 ± 151.33 0.724 204.50 ± 239.27 140.42 ± 157.10 0.003
VAI 1.45 ± 1.20 2.90 ± 3.61 0.0001 2.36 ± 1.52 3.90 ± 3.30 0.0001
LAP 20.93 ± 31.73 38.41 ± 40.60 0.0001 53.27 ± 52.23 74.38 ± 57.88 0.002

Note: values are expressed as mean ± SD. IR: insulin resistance; BMI: body mass index; WHR: waist-to-hip ratio; WHtR: waist-to-height ratio; E2: estradiol; T: testosterone; LH: luteinizing hormone; FSH: follicle-stimulating hormone; SHBG: sex hormone-binding globulin; FAI: free androgen index; FGS: fasting glucose; FIN: fasting insulin; F2h: 2-hour postprandial blood glucose; FI2h: 2-hour postprandial blood insulin; CHO: total cholesterol; TG: triglyceride; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; LP (a): lipoprotein (a); VAI: visceral adiposity index; LAP: lipid accumulation product.